Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Stanford University
With
Susan G. Komen Breast Cancer Foundation
To demonstrate iodide uptake capacity of breast cancer metastases by imaging women with iodide radioisotope (123I) and calculating potential ablative dose of radioactive iodide (131I).
Age
18–70
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
18 years of age or older
From whom informed consent can be obtained
Patient is able to provide a fluid (e.g. cyst fluid)
Patient with blood test that shows protein may allow iodide to accumulate in breast tissue
You may not be if
Children
Clareo Health | Scintigraphic Assessment of I- Transport in Metastatic Breast Cancer and Evaluation of I31I Ablative Therapy: (Part I) Radioiodide Imaging Study
